Intravitreal injections: a review of the evidence for best practice-Reference-Cited by-同舟云学术

Intravitreal injections: a review of the evidence for best practice

Published:2013-06-25 Issue:5 Volume:41 Page:500-507
ISSN:1442-6404
Container-title:Clinical & Experimental Ophthalmology
language:en
Short-container-title:Clin Experiment Ophthalmol

Author:

Fagan Xavier J,Al-Qureshi Salmaan

Publisher

Wiley

Subject

Ophthalmology

Reference54 articles.

1. Intravitreous injections;Bylsma;Clin Experiment Ophthalmol,2006

2. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection;Mason;Retina,2008

3. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the Diabetic Retinopathy Clinical Research Network laser-ranibizumab-triamcinolone clinical trials;Bhavsar;Arch Ophthalmol,2009

4. Ranibizimuab for age related macular degeneration;Rosenfeld;N Engl J Med,2006

5. NHMRC additional levels of evidence and grades for recommendations for developers of guidelines http://www.nhmrc.gov.au/_files_nhmrc/file/guidelines/stage_2_consultation_levels_and_grades.pdf

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eicosapentaenoic acid-rich omega-3 fatty acids supplementation may improve vision in dry age-related macular degeneration or Stargardt disease, as shown in MADEOS, a prospective, randomized, multicentre, double-blind, placebo-controlled pilot study;PharmaNutrition;2024-09

2. Endophthalmitis following intravitreal injections administered by junior medical officers in rural Western Australia;Clinical & Experimental Ophthalmology;2024-07-25

3. Comparing the in vitro efficacy of chlorhexidine and povidone-iodine in the prevention of post-surgical endophthalmitis;Journal of Ophthalmic Inflammation and Infection;2024-05-23

4. Häufigkeit und Wirkstoffverteilung intravitrealer Injektionen in deutschen Zentren 2015 bis 2021 – eine oregis-Studie;Die Ophthalmologie;2024-02-05

5. Intra-Anterior Chamber Injection of Ranibizumab in Advanced Pediatric Vitreoretinal Diseases;JAMA Ophthalmology;2024-02-01